Investing in Japan
Latest UpdatesKorean generic pharmaceutical exporter Ohsong Pharm establishes Japanese corporation
Dec 18, 2017
Ohsong Pharm Co., Ltd. is a Korean company that conducts sales and export of generic drugs.
They own Kuhnil and Penmix, a CMO (Contract Manufacturing Organization) and a CDMO (Contract Development and Manufacturing Organization) respectively, which deal with oral agents, penicillin injections and general injections within their group. Ohsong Pharm is responsible for conducting operations concerning these products aimed at the Japanese market.
The company has dealt with major Japanese generic pharmaceutical companies for more than a decade and established Brio Pharma Co., Ltd. in Tokyo in July 2017 for business expansion in Japan. At the same time, they are gearing up to develop and sell new generic drugs in Japan for which the patents are about to expire.
For the establishment of its Japanese corporation, the JETRO Invest Japan Business Support Center (IBSC) provided temporary office space, consultation on matters related to taxes, labor and licensing for pharmaceutical manufacturing and sales. In addition, referrals were made to accounting firms.